drugset / Trial / NCT00683865

Uncomplicated Pelvic Inflammatory Disease. Treatment With Moxifloxacin.

NCT00683865

Phase 3 Completed 749 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

Comparison of various antibiotics in treatment of uncomplicated pelvic inflammatory disease

Timeline

Start
2003-04
Primary completion
2004-10
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 500 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral
Comparator Ofloxacin Small molecule 400 mg Oral